← Back to feedRead original →
VERIFIEDET Finance·neutral
Aurobindo Pharma arm Eugia Pharma's Telangana unit gets warning letter from USFDA
AI Summary
- ·Aurobindo Pharma's subsidiary Eugia Pharma received a warning letter from the USFDA.
- ·The letter follows an inspection of their Telangana formulation manufacturing facility which had four observations.
- ·Existing US market supplies are unaffected by this development.